$Lineage Cell Therapeutics (LCTX.US)$ looking poised for goo...
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Benzinga Real-time News
·
09:06
Lineage Cell Therapeutics Inc (NYSE:LCTX) has entered into an exclusive worldwide collaboration and license agreement with Roche Holdings AG's (OTC:RHHBY) Genentech to develop and commercialize retinal pigment epithelium (RPE) cell therapy.
Benzinga Real-time News
·
09:06
Lineage Cell Therapeutics Inc (NYSE:LCTX) has entered into an exclusive worldwide collaboration and license agreement with Roche Holdings AG's (OTC:RHHBY) Genentech to develop and commercialize retinal pigment epithelium (RPE) cell therapy.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
`Not by might nor by power, but by my Spirit,' says the LORD
1017Followers
1Following
3287Visitors
Follow